Critics say that, if RFK Jr. is made secretary of the HHS, a radical antiestablishment medical movement with roots in past ...

Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...

President-elect Donald Trump has tapped Dr Jay Bhattacharya, a Stanford health economist, to lead the National Institutes of Health.

In the US, there was a 7.6% increase in the price of cancer drugs at 5 years post-launch and an 18.1% increase at 10 years, after adjusting for inflation. Prices of cancer drugs increase ...

In its accelerated approval decisions of new cancer drugs, the FDA might be underestimating the willingness of some patients ...

To run the US Centers for Disease Control and Prevention, Trump has turned to David Weldon, MD, a long-time internist who interrupted his medical career to represent a Florida district for 7 terms in ...

Imkeldi is supplied as a strawberry-flavored oral solution in a 140 mL, child-resistant, tamper-evident bottle.

(HealthDay News) — There are considerable differences in life expectancy between different groups in the US population, according to a study published in The Lancet. Researchers divided the US ...

A CXB boost continues to provide an organ preservation benefit at 5 years, though there is some local regrowth after 3 years, ...

Clinical factors associated with an increased risk of psychological distress included younger age, female sex, advanced pathological/tumor stage, and preoperative setting.

Source: Getty Images Mehmet Oz, President-elect Donald Trump’s choice to run the Centers for Medicare & Medicaid Services, ...